Discover
FHTX
Foghorn Therapeutics Inc.
5.01
2 x 3.64
2 x 6.15
bid
ask
+
0.13
2.66%
2 @ 04:00 AM
5.03 +0.02 (0.40%)
| Ytd | -7.22% | |
| 1y | 2.87% |
4.75
day range
5.11
3.27
52 week range
6.95
| Open | 4.90 | Prev Close | 4.88 | Low | 4.75 | High | 5.11 | Mkt Cap | 294.16M |
| Vol | 326.37K | Avg Vol | 173.07K | EPS | -1.17 | P/E | N/A | Forward P/E | -3.12 |
| Beta | 3.15 | Short Ratio | 7.62 | Inst. Own | 72.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 4.32 | 200-d Avg | 4.82 | 1yr Est | 12.00 |
| Income Statement | |||
| Total Revenue | 3.27M | ||
| Revenues (USD) | 3.27M | ||
| Gross Profit | 3.27M | ||
| Operating Expenses | 24.84M | ||
| Research and Development Expense | 18.26M | ||
| Selling, General and Administrative Expense | 6.58M | ||
| Operating Income | -21.57M | ||
| Net Income | -19.87M | ||
| Net Income Common Stock | -19.87M | ||
| Net Income Common Stock (USD) | -19.87M | ||
| Consolidated Income | -19.87M | ||
| Earnings per Basic Share | -0.29 | ||
| Earnings per Basic Share (USD) | -0.29 | ||
| Earnings per Diluted Share | -0.29 | ||
| Earning Before Interest & Taxes (EBIT) | -19.87M | ||
| Earning Before Interest & Taxes (USD) | -19.87M | ||
| Weighted Average Shares | 69.54M | ||
| Weighted Average Shares Diluted | 69.54M | ||
| Balance Sheet | |||
| Cash and Equivalents | 90.91M | ||
| Cash and Equivalents (USD) | 90.91M | ||
| Investments | 95.97M | ||
| Investments Current | 95.97M | ||
| Current Assets | 188.06M | ||
| Property, Plant & Equipment Net | 32.10M | ||
| Total Assets | 222.17M | ||
| Debt Current | 1.86M | ||
| Total Debt | 41.99M | ||
| Current Liabilities | 64.40M | ||
| Debt Non-Current | 40.13M | ||
| Total Liabilities | 298.58M | ||
| Accumulated Retained Earnings (Deficit) | -652.34M | ||
| Accumulated Other Comprehensive Income | -133.00K | ||
| Shareholders Equity | -76.41M | ||
| Shareholders Equity (USD) | -76.41M | ||
| Assets Non-Current | 34.10M | ||
| Total Debt (USD) | 41.99M | ||
| Deferred Revenue | 245.89M | ||
| Liabilities Non-Current | 234.17M | ||
| Trade and Non-Trade Payables | 3.32M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 799.00K | ||
| Net Cash Flow from Financing | 49.77M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.79M | ||
| Issuance (Purchase) of Equity Shares | 49.77M | ||
| Net Cash Flow from Investing | -17.72M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -17.72M | ||
| Net Cash Flow from Operations | -25.27M | ||
| Share Based Compensation | 2.38M | ||